Atlas Trials

Single Lipiflow Treatment to Reduce Pharmacologic Burden in DED

Clinical trial NCT06542276 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06542276
Sponsor
Dunes Eye Consultants
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
MGD-Meibomian Gland Dysfunction
Start date
2023-09-01
Primary completion
2024-02-28
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.